ADDvise receives order from SLL worth 4.8 MSEK + option of 3.3 MSEK

ADDvise subsidiary LabRum AB has received an allocation decision by Stockholm County Council (SCC) to deliver 100 CO incubators to NKS (New Karolinska Solna) and an option of another 66 CO incubators. The order amounts to 4.8 MSEK and the value of the option amounts to 3.3 MSEK which gives a total value of 8.1 MSEK. The order will be delivered during 2016 and the option during 2017.

- Our investment in instruments and equipment for research facilities and healthcare gives results. The growth in this segment is very good, says Rikard Akhtarzand CEO of ADDvise Group in a comment to the order.

The agreement has a standstill period until August 29. Not until then LabRum AB has the right to sign the agreement with SLL.


For further information, please contact:

Rikard Akhtarzand, CEO, +46 765-25 90 71


About ADDvise Group AB

ADDvise Group AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise Tillquist AB, LabRum AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical Tables Inc offers comprehensive solutions in the form of products and services to healthcare and research facilities. ADDvise Group's customers are located in both the private and public sectors. The Company's share is listed on First North Premier and Mangold Fondkommission AB, +46 8-503015 50, is the company's Certified Adviser and liquidity provider.

About Us

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier. Additional information is available at